Daily Practice Treatment and Influence of Visanne on the Patient Assessment of Quality of Life
Launched by BAYER · May 9, 2012
Trial Information
Current as of April 30, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female patients older than 18 years of age
- • Clinical or laparoscopic diagnosis of endometriosis
- • Having endometriosis related pain as leading symptom
- • Decision taken by physician to prescribe Visanne
- • Signed Informed Consent Form
- Exclusion Criteria:
- • Contraindications listed in the local summary of product characteristics (SPC) have to be considered.
About Bayer
Bayer is a global healthcare and life sciences company dedicated to advancing health and well-being through innovative research and development. With a strong commitment to improving patient outcomes, Bayer conducts clinical trials across various therapeutic areas, including oncology, cardiology, and women's health. The company leverages cutting-edge science and technology to develop breakthrough therapies, while adhering to the highest standards of ethical practices and regulatory compliance. Through collaboration with healthcare professionals and research institutions, Bayer aims to bring transformative solutions to the market, ultimately enhancing the quality of life for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Many Locations, , Jordan
Many Locations, , Kazakhstan
Many Locations, , Lebanon
Many Locations, , Russian Federation
Many Locations, , Saudi Arabia
Many Locations, , Ukraine
Many Locations, , Egypt
Many Locations, , Kuwait
Many Locations, , United Arab Emirates
Many Locations, , Qatar
Many Locations, , Belarus
Patients applied
Trial Officials
Bayer Study Director
Study Director
Bayer
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials